<DOC>
	<DOCNO>NCT01350791</DOCNO>
	<brief_summary>This study non-randomized , prospective , open-label registry compare efficacy safety Promus Element stent versus first-generation drug-eluting stent ( DES ) patient coronary artery disease .</brief_summary>
	<brief_title>Evaluation Effectiveness Safety PROMUS Element Stent ( IRIS-ELEMENT )</brief_title>
	<detailed_description>The Element Stent platform feature proprietary Platinum Chromium Alloy , design specifically coronary stent . This alloy , couple new stent architecture , design enable thinner strut , increase flexibility lower profile improve radial strength , recoil visibility . In addition , PROMUS Element Stent System incorporate new Apexâ„¢ Dilatation Catheter technology , design enhance deliverability complex lesion . Currently , limit data regard comparison PROMUS Element stent first-generation DES routine clinical practice . Therefore , perform large-scale real-world registry PROMUS Element stent .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients receive Promus Element stents The patient guardian agree study protocol schedule clinical followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethics Committee respective clinical site . Patients mixture DESs Terminal illness life expectancy &lt; 1 year Patients cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>